Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2379]

New drug demonstrates early promise in metastatic breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio...

New drug demonstrates early promise in metastatic breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Dr Adil I. Daud - University of California San Francisco School of Medicine...

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475 ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475...

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston...

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA

Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )

ecancermedicalscience Editor's Choice for April 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience Editor's Choice for April 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA

New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )

I-SPY 2 trial shows promising development for some breast cancer patients using...

Dr John W. Park - University of California, San Francisco Hellen Diller Family...

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )

Obesity and diabetes should be taken into account when planning breast cancer...

Dr Caterina Fontanella - German Breast Group, Neu-Isenberg, Germany

Obesity and diabetes should be taken into account when planning breast cancer treatment ( Dr Caterina Fontanella - German Breast Group, Neu-Isenberg, Germany )

European breast screening programmes

Dr Hilary Dobson - West of Scotland Cancer Network, Glasgow, UK

European breast screening programmes ( Dr Hilary Dobson - West of Scotland Cancer Network, Glasgow, UK )

Consensus on the treatment of breast cancer and early intervention using...

Prof Nadia Harbeck - University of Munich, Munich, Germany

Consensus on the treatment of breast cancer and early intervention using endocrine therapy ( Prof Nadia Harbeck - University of Munich, Munich, Germany )

Ganetespib in first-line treatment of women with metastatic HER2 positive or...

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )

Radiotherapy after mastectomy benefit for breast cancer that has spread to just...

Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan

Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes ( Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan )

More from ecancer